A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
Launched by UNIVERSITY OF SOUTHERN MISSISSIPPI · Aug 11, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new exercise method for people with knee osteoarthritis (OA) and obesity. The study uses a special system called the hip flexion feedback system (HFFS), which helps participants exercise by encouraging them to lift their knees higher while walking on a treadmill. This method aims to reduce pain and improve fitness without the high impact that traditional exercises like running can cause. Participants will be divided into two groups: one will use the HFFS for a 12-week exercise program, while the other will not exercise. The goal is to see how this new approach affects their fitness, pain levels, and mobility.
To be eligible for the trial, participants must be between 30 to 75 years old, have a body mass index (BMI) of 30 or higher, and have knee OA symptoms. They should also be relatively inactive, meaning they don't exercise regularly. Participants can expect to engage in a structured exercise program while having their heart rate monitored to ensure they are exercising at the right intensity. This study could lead to safer and more effective exercise options for people with osteoarthritis and obesity, and it may also help develop home-based exercise programs in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 30 to 75 years;
- • BMI ≥ 30.0 kg/m2 and ≤ 50.0 kg/m2;
- • Symptomatic knee OA (defined as a self- report of physician diagnosis of knee OA and current knee symptoms in at least one knee determined from a minimum score of 5 of 20 on the pain subscale of the WOMAC).
- • Sedentary (not meeting ACSM guidelines for physical activity)
- • Medical clearance for participation
- Exclusion Criteria:
- • Self- reported fibromyalgia, rheumatoid arthritis, or other systemic rheumatic disease.
- • Severe dementia or other memory loss condition
- • Active diagnosis of psychosis or current uncontrolled substance abuse disorder
- • Has been hospitalized for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months
- • Had a total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament tear in the past 6 months
- • Is on a waiting list for total joint replacement
- • Had an intra-articular injection in past 3 months or scheduled during the study period;
- • Has severely impaired hearing or speech
- • Is pregnant
- • Has a serious or terminal illness as indicated by referral to hospice or palliative care
- • Resides in a nursing home
- • Has any other health problems that would prohibit safe participation in the study
About University Of Southern Mississippi
The University of Southern Mississippi is a prominent academic institution dedicated to advancing research and education in various fields, including healthcare and clinical studies. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient outcomes and enhancing medical knowledge. Committed to ethical standards and rigorous scientific methodologies, the University of Southern Mississippi fosters collaboration among researchers, healthcare professionals, and the community to address critical health challenges and contribute to the advancement of evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hattiesburg, Mississippi, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported